IceCure Medical Ltd. 近日发布了其针对肾脏肿瘤的冷冻消融疗法五年期研究的顶线结果,数据表现积极。研究显示,患者在接受治疗后,五年无复发率分别达到89.4%和83.9%,凸显了该疗法在肾癌治疗领域的潜在价值。
IceCure Medical Ltd. 近日发布了其针对肾脏肿瘤的冷冻消融疗法五年期研究的顶线结果,数据表现积极。研究显示,患者在接受治疗后,五年无复发率分别达到89.4%和83.9%,凸显了该疗法在肾癌治疗领域的潜在价值。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.